Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rwanda | 19 | 2022 | 669 | 1.290 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2024 | 3440 | 1.030 |
Why?
|
Rural Population | 9 | 2024 | 2318 | 1.030 |
Why?
|
Blood Glucose Self-Monitoring | 3 | 2022 | 475 | 0.860 |
Why?
|
Hospitals, District | 6 | 2024 | 114 | 0.710 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 395 | 0.590 |
Why?
|
Education, Nursing, Continuing | 1 | 2017 | 69 | 0.580 |
Why?
|
Hematologic Tests | 1 | 2018 | 239 | 0.550 |
Why?
|
Health Services Accessibility | 9 | 2021 | 5512 | 0.500 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2022 | 12241 | 0.460 |
Why?
|
Mentors | 1 | 2017 | 672 | 0.400 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2021 | 954 | 0.360 |
Why?
|
Hyperlipidemias | 1 | 2016 | 773 | 0.360 |
Why?
|
Medical Oncology | 2 | 2020 | 2349 | 0.360 |
Why?
|
Delivery of Health Care | 4 | 2020 | 5375 | 0.340 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2020 | 2044 | 0.340 |
Why?
|
Malawi | 4 | 2024 | 309 | 0.330 |
Why?
|
Primary Health Care | 4 | 2022 | 4748 | 0.320 |
Why?
|
Feasibility Studies | 5 | 2024 | 5313 | 0.300 |
Why?
|
Laboratories | 1 | 2011 | 463 | 0.300 |
Why?
|
Nurses | 1 | 2017 | 2494 | 0.290 |
Why?
|
Relief Work | 1 | 2019 | 131 | 0.290 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 790 | 0.280 |
Why?
|
Referral and Consultation | 2 | 2020 | 3627 | 0.270 |
Why?
|
Rural Health Services | 3 | 2021 | 393 | 0.270 |
Why?
|
Drug Resistance | 1 | 2011 | 1595 | 0.250 |
Why?
|
Program Evaluation | 2 | 2018 | 2505 | 0.230 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5891 | 0.230 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2011 | 939 | 0.220 |
Why?
|
Tuberculosis | 2 | 2013 | 2029 | 0.210 |
Why?
|
Disasters | 1 | 2019 | 523 | 0.210 |
Why?
|
Hospitals, Rural | 2 | 2024 | 176 | 0.200 |
Why?
|
Quality Improvement | 1 | 2017 | 3858 | 0.200 |
Why?
|
Drugs, Essential | 2 | 2020 | 71 | 0.200 |
Why?
|
Hodgkin Disease | 2 | 2020 | 1386 | 0.190 |
Why?
|
Blood Glucose | 4 | 2024 | 6430 | 0.190 |
Why?
|
Kenya | 2 | 2016 | 757 | 0.180 |
Why?
|
Health Care Costs | 2 | 2015 | 3267 | 0.180 |
Why?
|
Mycobacterium tuberculosis | 1 | 2011 | 1929 | 0.180 |
Why?
|
Neoplasms | 3 | 2020 | 22385 | 0.180 |
Why?
|
Public Health | 1 | 2013 | 2682 | 0.170 |
Why?
|
Heart Failure | 6 | 2022 | 11858 | 0.160 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 3108 | 0.160 |
Why?
|
Insulin | 3 | 2022 | 6607 | 0.150 |
Why?
|
Nurse's Role | 1 | 2018 | 188 | 0.140 |
Why?
|
Rheumatic Heart Disease | 1 | 2018 | 164 | 0.140 |
Why?
|
Interviews as Topic | 2 | 2024 | 2740 | 0.140 |
Why?
|
Developing Countries | 4 | 2020 | 2903 | 0.140 |
Why?
|
Humans | 38 | 2024 | 768393 | 0.130 |
Why?
|
Wilms Tumor | 1 | 2018 | 379 | 0.130 |
Why?
|
Health Policy | 3 | 2017 | 2698 | 0.130 |
Why?
|
North Carolina | 2 | 2013 | 328 | 0.130 |
Why?
|
Africa | 1 | 2018 | 726 | 0.130 |
Why?
|
Nursing Staff, Hospital | 1 | 2018 | 350 | 0.120 |
Why?
|
Chronic Disease | 3 | 2022 | 9379 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2022 | 81801 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2018 | 899 | 0.120 |
Why?
|
Pathology | 1 | 2017 | 270 | 0.120 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 3236 | 0.120 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 748 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 424 | 0.110 |
Why?
|
Health Personnel | 3 | 2019 | 3380 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10377 | 0.110 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2020 | 617 | 0.110 |
Why?
|
Uganda | 1 | 2018 | 1351 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1065 | 0.110 |
Why?
|
Specialization | 1 | 2017 | 781 | 0.100 |
Why?
|
Female | 19 | 2024 | 397089 | 0.100 |
Why?
|
Adult | 14 | 2024 | 223640 | 0.100 |
Why?
|
Teaching | 1 | 2019 | 1172 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1509 | 0.100 |
Why?
|
Africa South of the Sahara | 3 | 2019 | 751 | 0.090 |
Why?
|
Hypertension | 3 | 2021 | 8615 | 0.090 |
Why?
|
Public Health Practice | 1 | 2013 | 221 | 0.090 |
Why?
|
Middle Aged | 11 | 2024 | 223491 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1959 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4352 | 0.090 |
Why?
|
Checklist | 1 | 2017 | 844 | 0.090 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2013 | 339 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1322 | 0.090 |
Why?
|
Geographic Information Systems | 1 | 2012 | 283 | 0.090 |
Why?
|
Transportation | 1 | 2011 | 217 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2021 | 2784 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2693 | 0.090 |
Why?
|
Syphilis | 1 | 2012 | 243 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2948 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1820 | 0.080 |
Why?
|
Male | 14 | 2024 | 364902 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2011 | 273 | 0.080 |
Why?
|
Sputum | 1 | 2011 | 512 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4047 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.080 |
Why?
|
Models, Organizational | 1 | 2011 | 548 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1484 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2465 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2537 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 653 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2240 | 0.070 |
Why?
|
Drug Costs | 1 | 2015 | 1196 | 0.070 |
Why?
|
Specimen Handling | 1 | 2011 | 708 | 0.070 |
Why?
|
HIV Infections | 3 | 2020 | 17575 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2912 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3922 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2398 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2018 | 2056 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1515 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6210 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13503 | 0.060 |
Why?
|
Antitubercular Agents | 1 | 2011 | 1391 | 0.050 |
Why?
|
Child, Preschool | 3 | 2020 | 42650 | 0.050 |
Why?
|
Liberia | 1 | 2022 | 176 | 0.050 |
Why?
|
Maryland | 1 | 2022 | 277 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3643 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 60049 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15939 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21162 | 0.050 |
Why?
|
Adolescent | 5 | 2020 | 89184 | 0.050 |
Why?
|
Infant | 2 | 2020 | 36510 | 0.040 |
Why?
|
Clinical Competence | 2 | 2018 | 4848 | 0.040 |
Why?
|
Senegal | 1 | 2020 | 255 | 0.040 |
Why?
|
Lost to Follow-Up | 1 | 2020 | 123 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26411 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 301 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4266 | 0.040 |
Why?
|
Bleomycin | 1 | 2020 | 493 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4614 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2020 | 205 | 0.040 |
Why?
|
Vinblastine | 1 | 2020 | 488 | 0.040 |
Why?
|
Haiti | 1 | 2020 | 553 | 0.040 |
Why?
|
Ethiopia | 1 | 2020 | 482 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 353 | 0.040 |
Why?
|
Bangladesh | 1 | 2020 | 741 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20224 | 0.040 |
Why?
|
Dacarbazine | 1 | 2020 | 560 | 0.040 |
Why?
|
Self Care | 1 | 2022 | 797 | 0.040 |
Why?
|
Child | 3 | 2020 | 80891 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5451 | 0.030 |
Why?
|
Long-Term Care | 1 | 2020 | 632 | 0.030 |
Why?
|
Boston | 1 | 2019 | 9371 | 0.030 |
Why?
|
Tanzania | 1 | 2020 | 1403 | 0.030 |
Why?
|
Helicobacter pylori | 1 | 2018 | 381 | 0.030 |
Why?
|
Poverty | 2 | 2018 | 2721 | 0.030 |
Why?
|
Capacity Building | 1 | 2017 | 265 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 2018 | 391 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 65379 | 0.030 |
Why?
|
Health Facilities | 1 | 2019 | 577 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 1082 | 0.030 |
Why?
|
Politics | 1 | 2021 | 821 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11254 | 0.030 |
Why?
|
Public Sector | 1 | 2015 | 266 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2229 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1758 | 0.030 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 584 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7861 | 0.030 |
Why?
|
Qualitative Research | 1 | 2024 | 3131 | 0.030 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.020 |
Why?
|
Income | 1 | 2020 | 1877 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39407 | 0.020 |
Why?
|
Policy Making | 1 | 2015 | 545 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1669 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40272 | 0.020 |
Why?
|
Geography | 1 | 2012 | 654 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8731 | 0.020 |
Why?
|
Drug Industry | 1 | 2015 | 793 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.020 |
Why?
|
Aged | 3 | 2018 | 171562 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6808 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2529 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2015 | 873 | 0.020 |
Why?
|
Health Care Reform | 1 | 2015 | 1262 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5099 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26375 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 12870 | 0.010 |
Why?
|
Prospective Studies | 2 | 2022 | 54920 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59686 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2017 | 4339 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15455 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74962 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3836 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6406 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11854 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41795 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21544 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15649 | 0.010 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_